Shanton Pharma Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Holding
- Established
- 2016-02-05
- Employees
- 1
- Market Cap
- -
- Website
- https://shantonpharma.com
SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Shanton Pharma Co., Ltd.
- Target Recruit Count
- 70
- Registration Number
- NCT06678581
- Locations
- 🇨🇳
Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China
Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.
- First Posted Date
- 2023-01-19
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Shanton Pharma Pte. Ltd.
- Target Recruit Count
- 87
- Registration Number
- NCT05690204
- Locations
- 🇺🇸
Idaho Site, Boise, Idaho, United States
🇺🇸Mississippi Site, Jackson, Mississippi, United States
🇺🇸Texas Site, The Woodlands, Texas, United States
Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients
- First Posted Date
- 2019-08-01
- Last Posted Date
- 2021-11-05
- Lead Sponsor
- Shanton Pharma Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT04040816
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Miami Research Associates, South Miami, Florida, United States
🇺🇸Advanced Clinical Research, Meridian, Idaho, United States
Placebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout Patients
- First Posted Date
- 2019-02-27
- Last Posted Date
- 2021-10-14
- Lead Sponsor
- Shanton Pharma Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT03857165
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸High Point Clinical Trials Center, High Point, North Carolina, United States
🇺🇸Avail - Accel Research Sites, DeLand, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath